DelveInsight's "Dry AMD Market Insights, Epidemiology, and Market Forecast 2032" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Dry AMD market size and shares analysis in the seven major markets (7MM). The report also covers emerging therapies, current treatment practices, Dry AMD Market Shares of the individual therapies, a detailed current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assess the underlying potential of the market.
Dry AMD Disease Overview
Age-related macular degeneration (AMD) is a degenerative disease of the center area of the ocular-posterior segment (the macula lutea) that causes slow degeneration in central vision and severe disability in affected persons. Clinically, AMD is classified according to different approaches. One such approach is that the disease is classified as an early-stage to late-stage (advanced AMD). The advanced AMD is classified into the nonexudative or atrophic form (dry AMD) and the exudative or neovascular form (wet AMD).
The diagnostic methods of AMD include fundus imaging, fluorescein angiogenesis (FA), indocyanine green angiography (ICGA), optical coherence tomography (OCT), Optical coherence tomography angiography (OCTA), and artificial intelligence (AI). These techniques play an important role in the diagnosis of AMD and have their unique advantages.
Report Insights
- Pipeline Analysis
- Market Opportunities
- Impact of upcoming Therapies
- Dry AMD Patient Population
- Dry AMD Market Size and Trends
- Dry AMD Therapeutic Approaches
The Dry AMD market analysis section of the report helps to understand the current and forecasted Dry AMD Market Trends and Growth by evaluating the impact of current therapies on the market, unmet needs, drivers, and barriers. The report gives complete detail of Dry AMD Market Size and Shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Dry AMD Therapeutics Market Outlook
A detailed understanding of the molecular mechanisms underlying wet AMD has led to several robust FDA-approved therapies. In contrast, there are not any approved treatments for dry AMD. The management of dry AMD consists of observation, regular follow-up evaluations, and documentation for timely recognition of visual function deterioration with appropriate rehabilitation and early CNV detection.
Dry AMD Epidemiology Forecast
The epidemiology section covers detailed insights about the patient pool for every seven major countries. It helps to recognize the causes of current and forecasted Dry AMD Epidemiology Trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
Dry AMD Epidemiology Subtype Segmentation
- Total Prevalent cases of Age-related Macular Degeneration
- Type-specific (Dry-AMD, Wet-AMD) Prevalence of Age-related Macular Degeneration
- Stage-specific Prevalence of Dry Age-related Macular Degeneration
- Age-specific Prevalence of Dry Age-related Macular Degeneration
- Diagnosed and Treatable cases of Dry Age-related Macular Degeneration
Some of the key companies in the Dry AMD Market include:
- Gemini Therapeutics
- Allegro Ophthalmics
- Gyroscope Therapeutics
- Alkeus Pharmaceuticals
- IVERIC bio
- Luxa Biotechnology
- Regenerative Patch Technologies
- OliX Pharmaceuticals
- Apellis Pharmaceuticals
- Ionis Pharmaceuticals
- NGM Biopharmaceuticals
- Eyestem
- CellCure Neurosciences
- Lin BioSciences
- Iveric Bio
- Stealth BioTherapeutics
- Gensight Biologics
And many others
Dry AMD Therapies covered in the report includes:
- Eyecyte RPE
- OLX301A
- CPCB-RPE1
- RPESC RPE 4W
- Zimura
- ALK-001
- GT005
- Risuteganib
- GEM103
And many more
For more details, visit: Dry AMD Market Growth Analysis